日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer

基于肿瘤微环境特征的免疫治疗反应预测评分用于预测晚期头颈癌的免疫治疗结果

Wang, Hui-Ching; Pan, Mei-Ren; Chan, Leong-Perng; Wu, Chun-Chieh; Hung, Yu-Hsuan; Du, Jeng-Shiun; Cho, Shih-Feng; Chou, Meng-Chun; Tsai, Hui-Ting; Wu, Che-Wei; Liu, Yi-Chang; Chen, Li-Tzong; Moi, Sin-Hua

Targeting lncRNA MALAT1 attenuates lenalidomide resistance via CD38 epigenetic modulation, oxidative stress-mediated cell death, and remodeling of the pro-tumor microenvironment in multiple myeloma

靶向lncRNA MALAT1可通过CD38表观遗传调控、氧化应激介导的细胞死亡以及重塑多发性骨髓瘤的促肿瘤微环境来减弱来那度胺耐药性。

Chang, Wen-Hsin; Liao, Wei-Ting; Yeh, Tsung-Jang; Moi, Sin-Hua; Liu, Yi-Chang; Hsiao, Hui-Hua; Wang, Hui-Ching; Du, Jeng-Shiun; Gau, Yuh-Ching; Yang, Ching-I; Lee, Ching-Ping; Hsu, Chin-Mu; Cho, Shih-Feng

Diagnostic challenges in plasma cell myeloma with lymphoplasmacytic lymphoma-feature

浆细胞骨髓瘤伴淋巴浆细胞淋巴瘤特征的诊断挑战

Wang, Min-Hong; Wu, Chun-Chieh; Cho, Shih-Feng

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.

γ-分泌酶抑制剂可增强靶向BCMA的双特异性抗体对多发性骨髓瘤细胞的疗效,而不会损害T细胞的活化和分化

Chen Hailin, Yu Tengteng, Lin Liang, Xing Lijie, Cho Shih-Feng, Wen Kenneth, Aardalen Kimberly, Oka Adwait, Lam Joni, Daley Mike, Lu Haihui, Munshi Nikhil, Anderson Kenneth C, Tai Yu-Tzu

Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area

重新审视巨细胞病毒感染与异基因造血干细胞移植后侵袭性真菌感染之间的关联:来自巨细胞病毒血清阳性率高地区的真实世界分析

Yeh, Tsung-Jang; Yang, Ching-I; Huang, Chien-Tzu; Wang, Min-Hung; Chuang, Tzer-Ming; Ke, Ya-Lun; Gau, Yuh-Ching; Du, Jeng-Shiun; Wang, Hui-Ching; Cho, Shih-Feng; Lee, Ching-Ping; Hsu, Chin-Mu; Hsiao, Hui-Hua; Liu, Yi-Chang

Bispecific antibodies in multiple myeloma treatment: A journey in progress

双特异性抗体在多发性骨髓瘤治疗中的应用:进展中的历程

Cho, Shih-Feng; Yeh, Tsung-Jang; Anderson, Kenneth C; Tai, Yu-Tzu

Is it reasonable for the use of Rh-ee blood? A hospital-based survey from a southern medical center in Taiwan

使用Rh-ee血型是否合理?来自台湾南部某医疗中心的医院调查

Hsiao, Hui-Hua; Yeh, Chi-Jung; Ting, Shuo-Chun; Chuang, Tzer-Ming; Ke, Ya-Lun; Yeh, Tsung-Jang; Gau, Yu-Chin; Du, Jeng-Shiun; Hsiao, Chi-En; Wang, Hui-Ching; Cho, Shih-Feng; Hsu, Chin-Mu; Liu, Yi-Chang

The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan

台湾南部地区不适合移植的多发性骨髓瘤患者接受硼替佐米联合沙利度胺和地塞米松(VTD)或硼替佐米联合美法仑和泼尼松龙(VMP)治疗的成本效益分析

Du, Jeng-Shiun; Kuo, Yi-Chun; Shi, Hon-Yi; Wang, Ming-Chung; Wang, Li-Ying; Chuang, Tzer-Ming; Ke, Ya-Lun; Yeh, Tsung-Jang; Gau, Yu-Ching; Wang, Hui-Ching; Cho, Shih-Feng; Hsiao, Samuel Yien; Liu, Yi-Chang; Hsu, Chin-Mu; Hsiao, Hui-Hua

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma.

CD8+抗BCMA mRNA CAR T细胞治疗多发性骨髓瘤的临床前评估

Lin Liang, Cho Shih-Feng, Xing Lijie, Wen Kenneth, Li Yuyin, Yu Tengteng, Hsieh Phillip A, Chen Hailin, Kurtoglu Metin, Zhang Yi, Andrew Stewart C, Munshi Nikhil, Anderson Kenneth C, Tai Yu-Tzu

The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience

节拍式替加氟-尿嘧啶化疗治疗局部晚期头颈部鳞状细胞癌的总体疗效和预后:一项真实世界队列研究

Yeh, Tsung-Jang; Chan, Leong-Perng; Tsai, Hui-Ting; Hsu, Chin-Mu; Cho, Shih-Feng; Pan, Mei-Ren; Liu, Yi-Chang; Huang, Chih-Jen; Wu, Che-Wei; Du, Jeng-Shiun; Wang, Hui-Ching